Bone metastases and breast cancer.
D000469:Alkaline Phosphatase / Q000032:analysis; D001859:Bone Neoplasms / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy; D001862:Bone Resorption / Q000187:drug effects; D001842:Bone and Bones / Q000000981:diagnostic imaging; D001943:Breast Neoplasms / Q000628:therapy*; D002135:Calcium-Binding Proteins / Q000032:analysis; D004002:Clodronic Acid / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D012968:Etidronic Acid / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008222:Lymphokines / Q000494:pharmacology; D015675:Osteocalcin; D010012:Osteogenesis / Q000187:drug effects; D000077268:Pamidronate; D010455:Peptides / Q000494:pharmacology; D011448:Prostaglandin Antagonists / Q000494:pharmacology; D011453:Prostaglandins / Q000502:physiology; D014057:Tomography, X-Ray Computed; D015291:Transforming Growth Factors
D002135:Calcium-Binding Proteins; D004164:Diphosphonates; D008222:Lymphokines; D010455:Peptides; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D004002:Clodronic Acid; D015675:Osteocalcin; C008718:osteoclast activating factor; D015291:Transforming Growth Factors; D000469:Alkaline Phosphatase; D012968:Etidronic Acid; D000077268:Pamidronate